NEUROCRINE BIOSCIENCES INC Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Neurocrine Biosciences Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Neurocrine Biosciences Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $6.5M.
  • Neurocrine Biosciences Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$57.2M, a 220% decline year-over-year.
  • Neurocrine Biosciences Inc annual Nonoperating Income (Expense) for 2023 was $81.2M.
  • Neurocrine Biosciences Inc annual Nonoperating Income (Expense) for 2022 was -$35.1M, a 3091% decline from 2021.
  • Neurocrine Biosciences Inc annual Nonoperating Income (Expense) for 2021 was -$1.1M, a 98% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$57.2M $6.5M +$32.1M Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 -$89.3M -$46.8M -$94.8M -198% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $5.5M -$64.8M -$75.7M -694% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $81.2M $47.9M +$33.4M +230% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-09
Q3 2023 $47.8M -$25.6M -$35.7M -353% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $83.5M $48M +$126M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$42.5M $10.9M -$7.4M -40.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 -$35.1M $14.5M -$8M -35.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-09
Q3 2022 -$27.1M $10.1M +$24.1M Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 -$51.2M -$78M -$72.7M -1372% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $21.5M $18.3M +$22.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$1.1M $22.5M +$52.6M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-09
Q3 2021 -$53.7M -$14M -$1.2M -9.38% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$52.5M -$5.3M -$11.9M -180% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$40.6M -$4.3M +$15.7M +78.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$56.3M -$30.1M -$19.9M -195% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 -$36.4M -$12.8M +$18.9M +59.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$55.3M $6.6M -$11.1M -62.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$44.2M -$20M -$18.4M -1150% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$25.8M -$10.2M -$7.19M -239% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 -$18.6M -$31.7M -$28.1M -791% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $9.53M $17.7M +$21.8M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 -$12.2M -$1.6M +$2.77M +63.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$15M -$3.01M +$1.93M +39.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-05
Q3 2018 -$16.9M -$3.56M +$1.57M +30.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 -$18.5M -$4.06M -$1.34M -49.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 -$17.2M -$4.37M -$5.98M -372% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 -$11.2M -$4.94M -$6.53M -410% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-07
Q3 2017 -$4.65M -$5.13M -$6.68M -431% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $2.03M -$2.72M -$4.27M -276% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $6.3M $1.61M +$13K +0.82% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-30
Q4 2016 $6.28M $1.59M +$159K +11.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-08
Q3 2016 $6.12M $1.55M +$140K +9.94% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $5.98M $1.55M +$213K +16% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $5.77M $1.59M +$497K +45.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $5.27M $1.43M +$409K +39.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $4.86M $1.41M +$427K +43.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $4.44M $1.34M +$355K +36.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $4.08M $1.1M +$213K +24.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $3.87M $1.02M +$136K +15.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $3.73M $982K +$107K +12.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-29
Q2 2014 $3.63M $980K +$55K +5.95% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 $3.57M $883K -$17K -1.89% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 $3.59M $888K -$20K -2.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-11
Q3 2013 $3.61M $875K -$9K -1.02% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $3.62M $925K +$46K +5.23% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $3.57M $900K -$6K -0.66% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $3.58M $908K +$24K +2.72% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-09
Q3 2012 $3.55M $884K -$58K -6.16% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $3.61M $879K -$1K -0.11% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-26
Q1 2012 $3.61M $906K -$37K -3.92% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 $3.65M $884K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-11
Q3 2011 $942K +$75K +8.65% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-31
Q2 2011 $880K +$142K +19.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-31
Q1 2011 $943K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q3 2010 $867K Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $738K Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.